Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

0.4123
Delayed Data
As of 1:47pm ET
 -0.0027 / -0.65%
Today’s Change
0.33
Today|||52-Week Range
1.64
-42.74%
Year-to-Date
No recent news for Opexa Therapeutics Inc.

Today’s Trading

Previous close0.42
Today’s open0.42
Day’s range0.41 - 0.43
Volume106,251
Average volume (3 months)1,589,773
Market cap$22.2M
Dividend yield--
Data as of 1:47pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+56.80%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+0.42%
P/E ratioNM
Price/Sales15.75
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...+0.05+7.73%
CLRBCellectar Bioscience...-0.04-1.29%
ALXAAlexza Pharmaceutica...+0.05+4.76%
PRPHProPhase Labs Inc-0.01-0.59%
Data as of 1:29pm ET, 07/29/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$1.3M
Annual profit (last year)-$15.1M
Net profit margin-1,183.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Neil K. Warma
Chief Financial Officer
Karthik Radhakrishnan
Corporate headquarters
The Woodlands, Texas

Forecasts